• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

The decision to stop or keep ADHD medication during pregnancy and breastfeeding is a difficult decision for women suffering from the condition. There is a lack of information about how long-term exposure to these drugs can affect the foetus.

A study recently published in Molecular Psychiatry demonstrates that children exposed to ADHD medication for adhd and odd during pregnancy do not develop neurological disorders such as hearing loss or vision, febrile seizures, or IQ impairment. The authors acknowledge that more high-quality research is needed.

Risk/Benefit Analysis

Pregnant women who use ADHD medications need to balance the advantages of using them against the risks to the fetus. Physicians do not have the information needed to provide clear recommendations but they can provide information regarding benefits and risks that can help pregnant women make informed decisions.

A study published in Molecular Psychiatry found that women who used ADHD medications in early pregnancy did not face a significantly higher risk of fetal cardiac malformations or major structural birth defects. Researchers conducted a large population-based case control study to compare the incidence of structural defects that were major in infants who were born to mothers who were taking stimulants during pregnancy. Clinical geneticists and pediatric cardiologists reviewed the cases to ensure correct case classification and to limit the chance of bias.

The study conducted by the researchers had some limitations. The researchers were unable, in the first place to distinguish the effects caused by the medication from the disorder. This limitation makes it difficult to determine whether the small differences observed in the groups that were exposed result from medication use or comorbidities that cause confusion. Researchers also did not examine the long-term effects for the offspring.

The study did find that infants whose mothers took ADHD medication during pregnancy were at a higher risk of being admitted to the neonatal intensive care unit (NICU) than infants whose mothers had not taken any medication or cut back on their medications prior to or during pregnancy. This increase was caused by central nervous system disorders. The increased risk of admission was not influenced by the stimulant medications used during pregnancy.

Women who were taking stimulant ADHD medications during pregnancy also had a higher likelihood of having to have a caesarean section or the baby was not scoring well on the Apgar scale (less than 7). These increases did not appear to be affected by the kind of medication used during pregnancy.

Researchers suggest that the small risks associated with the use adhd medication over the counter uk medications in early pregnancies may be offset by the greater benefits to both mother and baby from continuing treatment for the woman's condition. Doctors should discuss with their patients about this and try to help them develop coping skills that may reduce the impact of her disorder in her daily life and relationships.

Medication Interactions

As more women than ever are diagnosed with ADHD and treated with medication, the dilemma of whether to continue or end treatment during pregnancy is a question that doctors are having to face. These decisions are usually taken without clear and authoritative evidence. Instead, physicians must weigh their own knowledge in conjunction with the experiences of other doctors, and the research on the topic.

In particular, the issue of potential risks to the baby can be tricky. Many studies on this issue are based on observational data rather than controlled research, and their conclusions are often contradictory. Most studies limit their analysis to live births, which may underestimate the teratogenic impact that can lead to abortions or terminations of pregnancy. The study discussed in this journal club addresses these shortcomings by looking at data from both live and deceased births.

The conclusion is that while some studies have shown an association between ADHD medications and the risk of certain birth defects, others have not found any evidence of a link and the majority of studies have a neutral or slightly negative effect. As a result an accurate risk-benefit analysis must be done in each case.

It isn't easy, but not impossible, for women with ADHD to stop taking their medication. In fact, in an article recently published in the Archives of Women's Mental Health, psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can cause depression, feelings of loneliness and family conflict for those suffering from the disorder. A loss of medication may also affect the ability to drive safely and perform work-related tasks, which are vital aspects of normal life for those suffering from ADHD.

She suggests women who are unsure about whether or not to stop taking medication because of their pregnancy, consider educating family members, friends and colleagues about the condition, its impact on daily life, and the benefits of keeping the current treatment regimen. It can also help a woman feel supported in her decision. It is important to remember that certain medications are able to be absorbed through the placenta so if the patient decides to stop her ADHD medication during pregnancy and breastfeeding, she should be aware that the effects of the drug could be transferred to the child.

Birth Defects Risk

As the use and misuse of ADHD medication to treat symptoms of attention deficit hyperactivity disorder (ADHD) is increasing as does the concern about the potential effects of these drugs on the fetuses. Recent research published in the journal Molecular Psychiatry has added to the body of knowledge on this topic. Using two massive data sets, researchers were able to examine more than 4.3 million pregnancies and see whether the use of stimulant medications increased the risk of birth defects. Although the risk overall remains low, the scientists did find that first-trimester exposure to adhd medication how does it work medicines was associated with a slightly higher rate of specific heart defects, such as ventriculo-septal defect (VSD).

The researchers of the study could not discover any link between early use of medication and congenital anomalies like facial deformities or club feet. The results are in line with previous studies which showed an insignificant, but small increase in the number of cardiac malformations among women who started taking ADHD medication prior to the time of pregnancy. The risk grew in the latter half of pregnancy, when many women decide to stop taking their ADHD medications.

Women who took ADHD medications in the first trimester of their pregnancies were also more likely to experience a caesarean section, a low Apgar score after delivery and a baby that required breathing assistance at birth. The authors of the study were not able to eliminate bias due to selection because they restricted the study to women without other medical conditions that could have contributed to the findings.

The researchers hope that their research will help inform the clinical decisions of doctors who see pregnant women. They suggest that although a discussion of risks and benefits is important however, the decision to stop or keep medication must be based on each woman's needs and the severity of her ADHD symptoms.

The authors also advise that while discontinuing the medications is an alternative, it is not an option to consider due to the high prevalence of depression and other mental health problems in women who are pregnant or recently post-partum. Additionally, research suggests that women who stop taking their medications will have a difficult time adjusting to a life without them after the baby is born.

Nursing

It can be a stressful experience becoming a mother. Women with ADHD are often faced with a number of difficulties when they must deal with their symptoms, attend doctor appointments and prepare for the birth of a baby and adjust to a new routine. This is why many women elect to continue taking their ADHD medications throughout pregnancy.

The risk to a breastfeeding infant is minimal because the majority of stimulant medication passes through breast milk at low levels. However, the rate of medication exposure to the newborn can vary depending on dosage, how often it is administered, and the time of day the medication is administered. In addition, individual medications enter the baby's system differently through the gastrointestinal tract as well as breast milk and the impact of this on a newborn isn't fully understood.

Because of the lack of evidence, some doctors might be tempted to stop taking stimulant medications during the course of pregnancy. It's a difficult choice for the woman, who must weigh the advantages of taking her medication as well as the risk to the embryo. In the meantime, until more information is available, GPs can inquire about pregnant patients if they have a history of ADHD or if they plan to take medication in the perinatal phase.

A growing number of studies have shown that most popular adhd medication - discover this info here, women can safely continue taking their ADHD medication during pregnancy and while breastfeeding. In the end, many patients choose to do so, and in consultation with their physician, they have found that the benefits of keeping their current medication far outweigh any risks.

It is essential for women with ADHD who are contemplating breastfeeding to seek a specialist psychiatrist's guidance prior to becoming pregnant. They should discuss their medication with their prescriber and discuss the pros and cons for continuing treatment. This includes non amphetamine adhd medication-pharmacological methods. Psychoeducation is also required to help pregnant women suffering from ADHD be aware of the symptoms and underlying disorder. They should also be educated about treatment options and build coping mechanisms. This should be a multidisciplinary approach with the GPs, obstetricians, and psychiatrists. Pregnancy counseling should include discussion of a treatment plan for the mother and child, monitoring of signs of deterioration and, if needed adjustments to the medication regime.